The global serine protein kinase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). A serine protein kinase is a kinase enzyme that phosphorylates the OH group of serine or threonine. The major factor driving the demand for serine protein kinase is the increasing prevalence of cancer across the globe. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the increasing prevalence of cancer is driving the demand for serine protein kinase owing to their role in the initiation and treatment of progression of cancers.
To Request a Sample of our Report on Serine Protein Kinase Market: https://www.omrglobal.com/request-sample/serine-protein-kinase-market
Some major players in the market include AstraZeneca plc, Eli Lilly and Co., and Merck KGaA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, Eli Lilly and Company has entered into a global exclusive license agreement and strategic collaboration with Rigel Pharmaceuticals. The collaboration was aimed to co-develop and commercialise receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor R552 for all indications including autoimmune and inflammatory diseases.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- AstraZeneca plc, Eli Lilly and Co., and Merck KGaA, among others.
(Get 15% Discount on Buying this Report)
A full Report of Serine Protein Kinase Market is Available @ https://www.omrglobal.com/industry-reports/serine-protein-kinase-market
Global Serine Protein Kinase Market Report by Segment
By Type
- AZD-0156
- AZD-1390
- KU-55933
- M-3541
- Others
By Application
- Cancer
- Adenocarcinoma
- Others
Global Serine Protein Kinase Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
